Latest filing published 03 Dec 2025 for Ionis Pharmaceuticals INC, €1.4M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Joseph H. Wender is a declared insider at 2 companies (senior executive); the most frequent names are Ionis Pharmaceuticals Inc and OUTFRONT Media Inc. In total, 17 filings cover trades dated from 8 June 2021 to 1 December 2025.
No open-market purchase appears, only 5 sales worth €3.6M. Besides market trades, the filings include 12 option exercises. So far in 2025, the count stands at no purchases and 5 sales.
Most recently, on 3 December 2025, the filings show an open-market sale worth €1.4M in Ionis Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations